EVAXION BIOTECH

evaxion-biotech-logo

Evaxion Biotech A/S is a clinical-stage AI-immunology™ platform company decoding the human immune system to discover and develop novel immunotherapies to treat cancer and infectious diseases. Based on its proprietary and scalable AI-immunology core technology, Evaxion is developing a broad pipeline of novel product candidates which currently includes three patient-specific cancer immunotherapies, two of which are in Phase I/IIa clinical development. In addition, Evaxion is advancing a portfolio of vaccines to prevent bacterial and viral infections with one program currently in preclinical development against S. aureus (including Methicillin-resistant S. aureus) induced skin and soft tissue infections.
#SimilarOrganizations #People #Financial #Event #Website #More

EVAXION BIOTECH

Social Links:

linkedin

Linkedin

Industry:
Biotechnology

Founded:
2008-01-01

Address:
Copenhagen, Hovedstaden, Denmark

Country:
Denmark

Website Url:
http://www.evaxion-biotech.com

Total Employee:
11+

Status:
Active

Email Addresses:
[email protected]

Total Funding:
57 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Google Tag Manager Content Delivery Network Google Universal Analytics Google Maps Pound Sterling New Relic


Similar Organizations

affimed-logo

Affimed

Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.

idera-pharmaceuticals-logo

Idera Pharmaceuticals

Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.

paxvax-logo

PaxVax

PaxVax is a start-up developing candidate oral vaccines for key infectious diseases.

piqur-therapeutics-logo

PIQUR Therapeutics

PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.

protactivity-logo

ProtActivity

ProtActivity focusses on the development of vaccines against protozoal diseases.

versameb-logo

Versameb

Versameb is focusing on the discovery and development of innovative, next-generation RNA-based drugs.

Current Employees Featured

jens-kringelum_image

Jens Kringelum
Jens Kringelum Director, Genomic Immuno Oncology @ Evaxion Biotech
Director, Genomic Immuno Oncology
2018-01-01

andreas-holm-mattsson_image

Andreas Holm Mattsson
Andreas Holm Mattsson Chief Innovation Officer and Founder @ Evaxion Biotech
Chief Innovation Officer and Founder
2020-09-01

birgitte-rønø_image

Birgitte Rønø
Birgitte Rønø Chief Scientific Officer & Director of Cancer Vaccines @ Evaxion Biotech
Chief Scientific Officer & Director of Cancer Vaccines
2021-09-01

niels-moeller_image

Niels Moeller
Niels Moeller CBO and founder @ Evaxion Biotech
CBO and founder
2017-08-01

lars-wegner_image

Lars Wegner
Lars Wegner CEO @ Evaxion Biotech
CEO
2017-06-01

pär-comstedt_image

Pär Comstedt
Pär Comstedt Director, Infectious Disease Vaccines @ Evaxion Biotech
Director, Infectious Disease Vaccines
2018-01-01

Founder


andreas-holm-mattsson_image

Andreas Holm Mattsson

niels-moeller_image

Niels Moeller

Stock Details


Company's stock symbol is NASDAQ:EVAX

Investors List

lincoln-park-capital-fund_image

Lincoln Park Capital Fund

Lincoln Park Capital Fund investment in Post-IPO Equity - Evaxion Biotech

Key Employee Changes

Date New article
2021-09-21 Evaxion Biotech Appoints Dr. Birgitte Rønø as Chief Scientific Officer

Official Site Inspections

http://www.evaxion-biotech.com Semrush global rank: 6.69 M Semrush visits lastest month: 867

  • Host name: 76.76.21.21
  • IP address: 76.76.21.21
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Evaxion Biotech" on Search Engine

dfkcompany.com © 2022. All rights reserved